Effector CD8 +T cell IFN-γ production and cytotoxicity are enhanced by mild hyperthermia

International Journal of Hyperthermia

Volumn 28, Issue 1, 2012, Pages 9-18

  Mace, Thomas A ^a   Zhong, Lingwen ^a   Kokolus, Kathleen M ^a   Repasky, Elizabeth A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

cytotoxicity; fever; hyperthermia; interferon ; T lymphocytes

Indexed keywords

GAMMA INTERFERON; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL KILLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; GENETIC TRANSCRIPTION; HYPERTHERMIC THERAPY; LOW TEMPERATURE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL SURVIVAL; HOT TEMPERATURE; INTERFERON-GAMMA; MELANOMA-SPECIFIC ANTIGENS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPLEEN;

EID: 84855819090     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2011.616182     Document Type: Article

References (48)

1. Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996;35:731-744. (Pubitemid 26251128)
2. Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005;23:3079-3085. (Pubitemid 46224131)
3. Datta NR, Bose AK, Kapoor HK, Gupta S. Head and neck cancers: Results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 1990;6:479-486. (Pubitemid 20238373)
4. Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 1994;28:163-169. (Pubitemid 24012868)
5. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995;345:540-543.
6. Van der Zee J, Van Rhoon GC, Broekmeyer-Reurink MP, Kuijs AE, Van Den Berg AP, Treurniet-Donker D, et al. Clinical experience with local hyperthermia in Rotterdam. Adv Exp Med Biol 1990;267:383-386.
7. Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 2001;17:97-105. (Pubitemid 32185837)
8. Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998;40:287-295. (Pubitemid 28114370)
9. Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001;17:1-18. (Pubitemid 32058478)
10. Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: A randomised phase 3 multicentre study. Lancet Oncol 2010;11:561-570.
11. Baronzio G, Gramaglia A, Fiorentini G. Hyperthermia and immunity. A brief overview. In Vivo 2006;20:689-695.
12. Peer AJ, Grimm MJ, Zynda ER, Repasky EA. Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia. Immunol Res 2010;46:137-154.
13. Rowe RW, Strebel FR, Proett JM, Deng W, Chan D, He G, et al. Fever-range whole body thermotherapy combined with oxaliplatin: A curative regimen in a pre-clinical breast cancer model. Int J Hyperthermia 2010;26:565-576.
14. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998;58:3491-3494. (Pubitemid 28376536)
15. + ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother 2003;52:423-428. (Pubitemid 36831363)
16. + tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 2004;28:e26-31.
17. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 2005;102:18538-18543. (Pubitemid 43011261)
18. + tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res 2007;67:354-361. (Pubitemid 46142795)
19. + tumorinfiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection. Cancer Immunol Immunother 2010;59:1543-1549.
20. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313:1960-1964. (Pubitemid 44498003)
21. Ostberg JR, Gellin C, Patel R, Repasky EA. Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependent cellular immune response. J Immunol 2001;167:2666-2670. (Pubitemid 32768896)
22. + T cells into effector cells is enhanced by physiological range hyperthermia. J Leukocyte Biol 2011.
23. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 2003;21:713-758. (Pubitemid 37174546)
24. Atanackovic D, Nierhaus A, Neumeier M, Hossfeld DK. Hegewisch-Becker S. 41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol Immunother 2002;51:603-613. (Pubitemid 35440513)
25. Hanson DF. Fever and the immune response. The effects of physiological temperatures on primary murine splenic T-cell responses in vitro. J Immunol 1993;151:436-448. (Pubitemid 23207009)
26. Smith JB, Knowlton RP, Agarwal SS. Human lymphocyte responses are enhanced by culture at 40°C. J Immunol 1978;121:691-694. (Pubitemid 8404193)
27. Ostberg JR, Dayanc BE, Yuan M, Oflazoglu E, Repasky EA. Enhancement of natural killer (NK) cell cytotoxicity by feverrange thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol 2007;82:1322-1331. (Pubitemid 350133530)
28. Di YP, Repasky EA, Subjeck JR. Distribution of Hsp70, protein kinase C, and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure. J Cell Physiol 1997;172:44-54. (Pubitemid 27283346)
29. Cippitelli M, Fionda C, Di Bona D, Piccoli M, Frati L, Santoni A. Hyperthermia enhances CD95-ligand gene expression in T lymphocytes. J Immunol 2005;174:223-232. (Pubitemid 40007408)
30. Shim EK, Jung SH, Lee JR. Role of two adaptor molecules SLP-76 and LAT in the PI3K signaling pathway in activated T cells. J Immunol 2011;186:2926-2935.
31. Huang SC, Tsai HF, Tzeng HT, Liao HJ, Hsu PN. Lipid raft assembly and Lck recruitment in TRAIL costimulation mediates NF-kappaB activation and T cell proliferation. J Immunol 2011;186:931-939.
32. + CTL and directly mediates TCR signals leading to granule exocytosis-mediated cytotoxicity. J Immunol 2008;181:4716-4722.
33. Wang XY, Ostberg JR, Repasky EA. Effect of fever-like wholebody hyperthermia on lymphocyte spectrin distribution, protein kinase C activity, and uropod formation. J Immunol 1999;162:3378-3387. (Pubitemid 29313587)
34. Bonecchi R, Locati M, Mantovani A. Chemokines and cancer: A fatal attraction. Cancer Cell 2011;19:434-435.
35. Keeley EC, Mehrad B, Strieter RM. CXC chemokines in cancer angiogenesis and metastases. Adv Cancer Res 2010;106:91-111.
36. Grivennikov SI, Karin M. Inflammatory cytokines in cancer: Tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 2011;70:S104-108.
37. Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003;24:302-306.
38. + T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol 2004;172:989-999. (Pubitemid 38113758)
39. Ezernitchi AV, Vaknin I, Cohen-Daniel L, Levy O, Manaster E, Halabi A, et al. TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. J Immunol 2006;177:4763-4772. (Pubitemid 44469811)
40. + T cell function via L-arginine metabolism. Cancer Res 2009;69:3086-3094.
41. Di YP, Repasky E, Laszlo A, Calderwood S, Subjeck J. Hsp70 translocates into a cytoplasmic aggregate during lymphocyte activation. J Cell Physiol 1995;165:228-238.
42. Burd R, Dziedzic TS, Xu Y, Caligiuri MA, Subjeck JR, Repasky EA. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol 1998;177:137-147. (Pubitemid 28421530)
43. Wang XY, Kazim L, Repasky EA, Subjeck JR. Characterization of heat shock protein 110 and glucoseregulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol 2001;166:490-497. (Pubitemid 32038468)
44. Tanaka K, Ito A, Kobayashi T, Kawamura T, Shimada S, Matsumoto K, et al. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. Int J Cancer 2005;116:624-633. (Pubitemid 41099200)
45. Guo J, Zhu J, Sheng X, Wang X, Qu L, Han Y, et al. Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma. Int J Cancer 2007;120:2418-2425. (Pubitemid 46642129)
46. Patel VP, Moran M, Low TA, Miceli MC. A molecular framework for two-step T cell signaling: Lck Src homology 3 mutations discriminate distinctly regulated lipid raft reorganization events. J Immunol 2001;166:754-764. (Pubitemid 32060225)
47. Huse M, Quann EJ, Davis MM. Shouts, whispers and the kiss of death: Directional secretion in T cells. Nat Immunol 2008;9:1105-1111.
48. + T cells. J Exp Med 2003;198:569-580. (Pubitemid 37040391)